Allegaert, Karel, Maissa Rayyan, Veerle Cossey, and Chris Van Geet. “Subcutaneous Palivizumab (Synagis®) Administration in an Infant With Congenital Type 2B Von Willebrand Disease”. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM) 4, no. 1 (January 27, 2015): e040104. Accessed July 17, 2024. https://jpnim.com/index.php/jpnim/article/view/040104.